Seeing Is Believing
VTVT is currently covered by 1 analysts with an average price target of $86.47. This is a potential upside of $50.89 (143.03%) from yesterday's end of day stock price of $35.58.
vTv Therapeutics's activity chart (see below) currently has 4 price targets and 6 ratings on display. The stock rating distribution of VTVT is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 22.22% with an average time for these price targets to be met of 64.67 days.
Highest price target for VTVT is $47, Lowest price target is $47, average price target is $47.
Most recent stock forecast was given by EMILY BODNAR from HC WAINWRIGHT on 19-Dec-2025. First documented stock forecast 30-May-2019.
Currently out of the existing stock ratings of VTVT, 3 are a BUY (100%).
Analyst name
Rating
Rating initiation date
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
Since 09-Apr-2025
$47
$11.42 (32.10%)
$36
23 days ago
(19-Dec-2025)
2/3 (66.67%)
$12.28 (35.37%)
194
Buy
Since 17-Aug-2022
$80
$44.42 (124.85%)
3 years 4 months 25 days ago
(17-Aug-2022)
0/1 (0%)
$28.4 (55.04%)
Buy
Since 30-May-2019
$240
$204.42 (574.54%)
5 years 11 months 1 days ago
(10-Feb-2020)
0/1 (0%)
$112 (87.50%)
What is VTVT (vTv Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on VTVT (vTv Therapeutics) with a proven track record?
Which analyst has the current lower performing score on VTVT (vTv Therapeutics) with a proven track record?
Which analyst has the most public recommendations on VTVT (vTv Therapeutics)?
Which analyst is the currently most bullish on VTVT (vTv Therapeutics)?
Which analyst is the currently most reserved on VTVT (vTv Therapeutics)?